)
Company research29 Apr 2026
Target Corporation: The Business Behind the Bullseye
How Target grew from a Minneapolis dry goods store into a retail giant, blending discount pricing with design and private-label power.
Prelude Therapeutics
Prelude Therapeutics (PRLD) investor relations material
Prelude Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary29 Apr, 2026
Executive summary
Annual meeting scheduled for June 9, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by June 8, 2026.
Voting matters and shareholder proposals
Election of three Class III directors: Krishna Vaddi, Paul Scherer, and Katina Dorton, with board recommending a vote in favor.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote to approve 2025 executive compensation (say-on-pay).
Advisory vote on the frequency of future say-on-pay votes.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Board recommends all director nominees for election to Class III positions.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Prelude Therapeutics
- Annual meeting covers director elections, auditor ratification, and executive pay votes.PRLD
Proxy filing29 Apr 2026 - Advancing first-in-class targeted therapies for cancer with strong clinical and financial momentum.PRLDCorporate presentation22 Apr 2026
- Pipeline prioritizes JAK2V617F, KAT6A, and CALR programs, with strong funding through 2027.PRLDConference10 Mar 2026
- Pipeline advances in JAK2V617F and KAT6A programs drive innovation and financial strength.PRLDCorporate presentation10 Mar 2026
- Reduced net loss and strong cash position support clinical progress for key oncology programs.PRLDQ4 202510 Mar 2026
- Advancing first-in-class SMARCA2 and CDK9 therapies with key data expected this year.PRLDGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
- SMARCA2 and CDK9 programs advance toward key data readouts, backed by strong financials.PRLDJefferies 2024 Global Healthcare Conference1 Feb 2026
- Early clinical activity and tolerability observed for a selective SMARCA2 degrader in SMARCA4-mutated cancers.PRLDStudy Update20 Jan 2026
- Promising SMARCA2 degraders advance in trials, with key data and milestones expected in 2025.PRLDThe Citizens JMP Hematology and Oncology Summit Conference12 Jan 2026
Next Prelude Therapeutics earnings date
Q1 202613 May, 2026
Prelude Therapeutics
Next Prelude Therapeutics earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
Frequently asked questions
Explore our global coverage